Pantoprazole

Is pantoprazole safe?

Yes. Pantoprazole, sold as Protonix in the US and as cheap generics everywhere, is a proton pump inhibitor (PPI) that cuts stomach acid. It has no boxed warningBoxed warningThe strongest safety warning the US FDA puts on a medicine's label, printed inside a black border at the top.More in the glossary, no dependence, a very wide overdose marginOverdose marginHow far a normal dose is from a harmful one. A wide margin means an accidental extra dose is unlikely to cause serious harm.More in the glossary and more than 25 years of US use. In 2024 it was the 16th most prescribed US medicine, with about 34.9 million prescriptions for 9.3 million people (ClinCalc). We score it 86, the same as omeprazole.

As with any PPI, the open questions are about years of daily use rather than a short course. Pantoprazole has one clear advantage over omeprazole: fewer drug interactions, including with the blood thinner clopidogrel.

What the big trial showed

Most worries about PPIs come from observational studies, which compare people who take them with people who do not. PPI users tend to be older and sicker, so links with dementia, kidney disease, pneumonia and heart attacks are hard to untangle.

The COMPASS trial did something unusual: it randomised 17,598 people with heart or artery disease to pantoprazole 40 mg a day or a placebo and followed them for a median of 3 years. Published in Gastroenterology in 2019, it found no significant difference in pneumonia, fractures, chronic kidney disease, diabetes, dementia, cancer, heart disease or deaths. The one difference was enteric (gut) infections, 1.4% on pantoprazole and 1.0% on placebo. C. difficile infections were about twice as common, but with only 13 cases in total the gap was not statistically significant.

That is reassuring, though not the final word. The trial followed people for 3 years, not 10, and some label risks, such as low B12, take longer to appear.

Long-term risks on the label

The US label lists these for long-term or high-dose use:

• C. difficile diarrhoea, especially in hospital. Diarrhoea that does not settle needs a doctor.
• Low magnesium, reported rarely after at least 3 months and usually after a year. It can cause cramps, an irregular heartbeat or seizures, and can pull down calcium and potassium. The label suggests doctors consider checking levels in people also on digoxin or diuretics such as hydrochlorothiazide.
• Low vitamin B12 with daily use for more than about 3 years.
• Fractures of the hip, wrist or spine with high doses or use for a year or longer.
• Fundic gland polyps, usually harmless stomach polyps that become more likely after a year.
• Rarer reactions: acute kidney inflammation, cutaneous lupus and severe skin reactions.

If you take a PPI for years, ask whether your doctor should check magnesium or vitamin B12. Do not start supplements to "cover" the PPI without asking, because the right answer depends on your blood results.

Pantoprazole vs omeprazole

	Pantoprazole	Omeprazole
Usual adult dose	40 mg once a day	20 to 40 mg a day
Clopidogrel	No clinically important effect; no dose change	Label says avoid
Rilpivirine (HIV)	ContraindicatedContraindicationA situation in which a medicine should not be used, because the risk clearly outweighs any benefit, such as a known allergy to it.More in the glossary	Contraindicated
Boxed warningBoxed warningThe strongest safety warning the US FDA puts on a medicine's label, printed inside a black border at the top.More in the glossary	None	None

Both are broken down mainly by the liver enzyme CYP2C19CYP450 enzymesA family of liver enzymes that break down many medicines. When another drug or supplement speeds them up or slows them down, drug levels change.More in the glossary. The difference is that omeprazole also blocks CYP2C19, which is the enzyme that turns clopidogrel into its active form. Pantoprazole does this much less, which is why doctors often choose it for people on clopidogrel after a stent.

Interactions to check

• Rilpivirine: contraindicatedContraindicationA situation in which a medicine should not be used, because the risk clearly outweighs any benefit, such as a known allergy to it.More in the glossary, because less acid means less of the HIV drug is absorbed. Atazanavir and nelfinavir are also affected.
• Warfarin: INR can rise, and the label reports abnormal bleeding; INR checks are advised.
• High-dose methotrexate: levels can rise and stay high.
• Drugs that need acid to be absorbed: iron salts, some cancer drugs (erlotinib, dasatinib, nilotinib), mycophenolate, ketoconazole and itraconazole.
• Blood and urine tests: PPIs can raise chromogranin A, a tumour marker, and can cause false-positive urine screens for THC.

Who should be careful

• Anyone with warning signs that need investigation rather than acid suppression: trouble swallowing, weight loss, vomiting blood, black stools, or new heartburn over about 55. The label warns that symptom relief does not rule out stomach cancer.
• People on HIV treatment, high-dose methotrexate or warfarin.
• People with osteoporosis, low magnesium or low B12.
• Anyone in hospital or after antibiotics who develops persistent diarrhoea.

How we scored it

Overdose marginOverdose marginHow far a normal dose is from a harmful one. A wide margin means an accidental extra dose is unlikely to cause serious harm.More in the glossary (95), dependence (92) and track record (92) are strong. Interactions (76) scores better than omeprazole because of the clopidogrel difference, while serious side effects (85) and regulatory warnings (75) reflect the class-wide label warnings on long-term use rather than anything specific to pantoprazole.